Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imiquimod.

Robert B Skinner1

  • 1Department of Medicine, Division of Dermatology, University of Tennessee Health Science Center, 956 Court Avenue, Room E336, Memphis, TN 38163, USA. rollerbob51@aol.com

Dermatologic Clinics
|May 22, 2003
PubMed
Summary
This summary is machine-generated.

Imiquimod, an immune response modifier, effectively treats infectious skin conditions like genital warts by stimulating localized immunity. It offers a low recurrence rate and convenient self-application, outperforming other treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blistering Disease During the Treatment of Chronic Hepatitis C With Ledipasvir/Sofosbuvir.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2019
Same author

Space heater-induced bullous erythema ab igne.

Cutis·2017
Same author

What is your diagnosis? mycosis fungoides.

Cutis·2016
Same author

Staphylococcal scalded skin syndrome in pregnancy.

Cutis·2015
Same author

Vegetative sacral plaque in a patient with human immunodeficiency virus.

Cutis·2015
Same author

Necrolytic acral erythema in an adolescent.

Pediatric dermatology·2011
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Area of Science:

  • Immunology
  • Dermatology
  • Pharmacology

Background:

  • Imiquimod is a pioneering immune response modifier.
  • It activates Toll-like receptor 7 (TLR-7), mimicking microbial antigens to provoke an immune response.
  • This response involves the production of interferon-alpha (IFN-alpha) and tumor necrosis factor-alpha (TNF-alpha).

Purpose of the Study:

  • To review the efficacy of imiquimod in treating various infectious skin conditions.
  • To highlight its mechanism of action involving localized immune stimulation.
  • To compare its recurrence rate for genital warts with other treatments.

Main Methods:

  • Review of clinical data and case reports on imiquimod use.
  • Analysis of immune response pathways, including TLR-7 activation and cytokine production.

Related Experiment Videos

  • Comparison of genital wart clearance and recurrence rates with existing therapies.

    • Main Results:

    • Imiquimod demonstrates a 50-60% clearance rate for genital warts with a 12-20% recurrence rate, the lowest among current treatments.
    • Effective in treating common, plantar, and flat warts, molluscum contagiosum, and leishmaniasis.
    • Combination therapy enhances efficacy for common and plantar warts.

    Conclusions:

    • Imiquimod is a valuable self-applied treatment for infectious skin conditions, offering a favorable recurrence profile for genital warts.
    • Its mechanism involves targeted immune stimulation, potentially applicable to other conditions.
    • Further research may explore its role in treating conditions with suspected infectious etiologies.